Flagstar Financial, Inc.
FLG is still a turnaround, but the stock at 0.73x book and 1.36x sales is pricing in too much permanent impairment relative to a business that has returned to profitability, rebuilt capital to 13.16% CET1, and guided to a sharp earnings step-up in 2027 despite a messy 2026 reset.
The market is still pricing FLG like a damaged regional bank, and on trailing numbers that is fair. FY2025 revenue fell 8.1% to $4.7B, operating margin was -36.1%, net margin was -29.0%, and the headline 417.01x P/E is useless for valuation because the earnings base has only just crossed back into positive territory. What creates the opportunity is that the operating direction has clearly changed before the accounting history has had time to catch up. The latest quarter showed third straight profitability, PPNR up 51% QoQ, expense control with opex down 3% QoQ to $427M, and a better funding profile with $700M core deposit growth ex-brokered.
The stock works if two things happen. First, commercial banking has to keep replacing runoff elsewhere. That part is tangible already: $2.8B of C&I originations, $2.0B net C&I growth, and a Q3 pipeline above $2B. Second, credit has to stop overwhelming income recovery. That is less proven. FLG reduced substandard loans by $375M QoQ and criticized/classified loans by 9% YoY, but nonaccruals are still $2.8B and charge-offs hit $99M in Q2. The company is improving, but it is not clean.
That tension is exactly why the stock is interesting but not a high-conviction call. At 0.73x book and 1.36x sales, the market is still skeptical that normalized earnings are durable. Yet management now has enough capital, with 13.16% CET1, to authorize a $250M buyback while continuing to pay down wholesale funding and reposition the loan book. That capital cushion matters because it gives FLG time to finish the repair without needing heroic macro help.
The rating stays BUY because the upside path does not require perfection, only continued evidence that 2026 is the transition year and 2027 is the earnings year. What keeps conviction low is simple: management cut guidance again, the latest quarter missed consensus by 21.8%, and the shares already sit just 7.9% below the 52-week high. This is a turnaround that now needs proof, not just promises.
C&I momentum holds above the current $2B+ pipeline, deposit costs keep easing, buybacks start, and the market begins discounting the $1.60-$1.70 2027 earnings run rate.
FLG delivers gradual NIM stabilization, steady C&I growth, and enough credit improvement to keep the turnaround intact, supporting the engine's $17.92 target.
Credit stays sticky, nonaccruals remain near $2.8B, the 2027 EPS bridge loses credibility, and the stock drifts back toward the lower end of its $10.57-$15.44 52-week range.
Quant call aligns with analyst consensus (Strong Buy: 7 buy / 3 hold / 0 sell).
The single greatest edge an investor can have is a long-term orientation.
The stock is not investable on trailing earnings, with a headline 417.01x P/E, but it is investable if the market starts underwriting management's $1.60-$1.70 adjusted EPS target for 2027, which would put the shares on a far more normal forward earnings frame than the backward-looking multiple implies. The moat today is narrow and mostly balance-sheet and customer-relationship based, but it can improve over 3-5 years if FLG keeps shifting toward commercial and private-bank deposits and away from volatile mortgage-dependent revenue. AI is not a growth engine here in the way it is for software, but it can matter through underwriting, servicing, and operating-cost control, and FLG needs those efficiency gains because scale alone is not enough. Regulation and credit discipline remain the real swing factors, since a bank with 13.16% CET1 can absorb cleanup, but it cannot earn a premium multiple unless nonaccruals and charge-offs visibly roll over.
- Management now guides FY2027 adjusted EPS of $1.60-$1.70, versus FY2026 adjusted EPS of $0.40-$0.50, implying a major earnings power inflection if credit and mix normalize.
- Capital is stronger than the market gives credit for, with 13.16% CET1 supporting a newly authorized $250M buyback even after elevated nonaccruals.
- Operating trends are improving beneath the headline outlook cut: Q2 EBITDA margin reached 7.5%, up from 6.4% in Q1 and -3.6% a year ago, while operating expenses fell 3% QoQ to $427M.
- FLG posted its third straight quarter of profitability, with adjusted EPS improving to $0.05 from a $0.14 loss a year ago, showing the restructuring is finally producing visible earnings traction.
- Commercial banking is gaining momentum: $2.8B C&I originations produced $2.0B net C&I growth, and management said the Q3 pipeline is above $2B, which matters because C&I is replacing lower-quality or lower-return asset exposure.
- Funding and expense trends improved together in Q2, with $700M core deposit growth ex-brokered, $900M growth in commercial/private bank deposits, and a 5 bps QoQ reduction in interest-bearing deposit costs.
- Credit cleanup is painful but not directionless: substandard loans fell $375M QoQ, criticized and classified loans declined 9% YoY, and $1.1B of CRE runoff occurred at par, reducing balance sheet risk.
- Management cut both 2026 and 2027 outlooks, with FY2026 EPS now only $0.40-$0.50, because faster CRE payoffs, weaker DDA mix, and softer mortgage gain-on-sale are hitting NII and margin assumptions.
- Asset quality is still the core problem: Q2 net charge-offs rose to $99M, nonaccrual loans reached $2.8B, and that level is already above management's current FY2026 year-end expectation of $2.3B.
- Trailing profitability remains very weak, with FY2025 revenue down 8.1%, operating margin -36.1%, net margin -29.0%, and FCF -$0.2B in the financial snapshot, which explains the stock's low quality score of 31/100.
- The stock is no longer deeply discounted on near-term sentiment, trading 6.9% above its 200-day average and only 7.9% below its 52-week high, so any miss against the October setup could hit harder than if shares were still near the lows.
| Metric | Value | Context |
|---|---|---|
| Price target | $17.92 | 26.1% upside vs current $14.22, Low confidence, basis earnings_growth_blend |
| Current price / 52-week position | $14.22 | -7.9% vs $15.44 high, +6.9% above $13.31 200-day average, -66.4% vs 5-year high $42.33 |
| FY2025 revenue | $4.7B | -8.1% YoY, showing the turnaround has not yet reached the full-year P&L |
| FY2025 EPS | -$0.51 | -79.2% YoY, still poor on a trailing basis despite recent quarterly profitability |
| FY2025 operating margin | -36.1% | Worse than prior year's -21.6%, highlights how depressed the trailing cost/revenue structure remains |
| Valuation | P/E 417.01 | P/S 1.36 | P/B 0.73 | P/E is distorted and far above peer average 13.9, while P/S is below peer 3.1 and P/B implies skepticism on franchise quality |
| Balance sheet and leverage | Debt/Equity 1.34 | Total debt $10.9B | Leverage is meaningful but manageable in the context of a bank still rebuilding earnings and de-risking CRE |
| Capital and buyback | CET1 13.16% | Buyback authorization $250M | Strong capital cushion is the key offset to ongoing credit stress |
| Q2 2026 profitability | EBITDA $0.08B on $1.05B revenue | Margin 7.5%, up from 6.4% in Q1 and -3.6% in prior-year Q2 |
| Guidance | FY2026 adj. EPS $0.40-$0.50 | FY2027 adj. EPS $1.60-$1.70 | Outlook was cut, but still implies a sharp earnings ramp in 2027 |
| Credit metrics | Nonaccrual loans $2.8B | Q2 net charge-offs $99M | Largest overhang, especially since management expects year-end nonaccruals around $2.3B |
| Risk and short interest | Risk score 66/100 | Short interest 13.04% | Risk is high, but elevated short positioning can amplify upside if credit data improves |
The biggest risk is that credit normalization takes longer than management expects, because nonaccrual loans are $2.8B today versus a $2.3B year-end target, which would jeopardize the path from $0.40-$0.50 EPS in 2026 to $1.60-$1.70 in 2027.
The next catalyst is Q3 earnings on October 23, 2026, especially whether June NIM really was the floor, whether C&I growth stays near Q2's $2.0B, and whether nonaccruals begin moving toward $2.3B.
Ownership is concentrated, with the top three institutions holding 78.6%, which can stabilize the shareholder base but can also amplify moves when views change. Short interest is elevated at 13.04%, or 34.8M shares, with 7.4 days-to-cover, so the name can squeeze on cleaner credit data or a guidance hold. Options positioning is mildly supportive, with a positive gamma regime and zero-gamma at $13.24, below spot, which suggests near-term flows are not fighting the tape unless the stock breaks meaningfully lower.
Revenue fell 8.1% YoY, reflecting pressure from balance-sheet shrink, funding mix, and weaker mortgage-related income.
This is the current growth engine, with $2.0B net C&I growth and a Q3 pipeline above $2B.
Deposit mix is improving, which matters more than raw volume because lower-cost, relationship-based funding supports NIM recovery.
CRE is intentionally shrinking; that lowers risk over time but is currently reducing earning assets and pressuring near-term NII.
Management called out softer mortgage gain-on-sale as a reason for the lowered 2026-2027 outlook, indicating this is still a swing factor in mix quality.
Flagstar posted a profitable Q2 but cut 2026-2027 outlook on faster CRE runoff and weaker revenue mix.
Execution has improved, but credibility is still rebuilding. On the positive side, management said in 2024 Q3 that margin had bottomed, and current commentary from CFO Lee Smith, "I am looking at that as a floor, and that was the reason for pointing out the June NIM margin," suggests that directional view has largely held, with Q2 EBITDA margin improving to 7.5% from 6.4% in Q1 and -3.6% a year earlier. Management also kept the long-term 2027 frame alive in late 2024, and today still guides to $1.60-$1.70 adjusted EPS for 2027, even after cutting 2026 and 2027 outlook on the latest call. On the negative side, the 2024 warning that nonaccruals would stay elevated through 2026 proved accurate, and current $2.8B nonaccruals versus a $2.3B year-end target show the cleanup is taking longer than investors want. The earnings beat/miss record is mixed, with four beats and four misses across the last eight quarters, including the latest -21.8% miss, which argues for only low conviction despite clear operational progress.
EPS for '26 is now forecast to be in the $0.40 to $0.50 range and EPS for '27 is forecast to be in $1.60 to $1.70 range.
I would suggest that we see consistent loan growth going forward, consistent with what we delivered in the second quarter.
I am looking at that as a floor, and that was the reason for pointing out the June NIM margin.
Our second quarter operating results reflect our third consecutive quarter of profitability and improved earnings.
As we look through the end of the year, we expect to end the year at about $2.3 billion.
FLG's moat is limited and comes from deposit relationships, commercial banking ties, and the ability to recycle excess capital into loan growth while weaker competitors stay defensive. That moat is not especially durable today because profitability is still rebuilding and the franchise has to earn back trust after credit issues. It becomes more durable only if management turns recent $700M core deposit growth and $2.0B C&I growth into a cleaner, lower-cost, relationship-heavy bank with less exposure to episodic mortgage and troubled CRE earnings.
Capital allocation has turned more credible now that CET1 stands at 13.16% and management authorized a $250M share buyback. That said, actual shareholder return has been minimal so far, with deep-dive data showing $0.0B buybacks and $0.0B dividends, which is appropriate while credit is still being cleaned up. The better use of capital today is balance-sheet repair, selective C&I growth, and paying down expensive funding, as shown by the $250M reduction in FHLB advances.
FLG rates BUY, Low conviction. The stock is still a turnaround with real credit risk, but the combination of 0.73x book, 13.16% CET1, improving quarterly profitability, and a credible path to much higher 2027 earnings leaves room for upside from $14.22. This is not a clean story and it is not early in the price move, so sizing matters. The thesis breaks if nonaccruals fail to move down from $2.8B, if C&I growth stalls below the current $2B+ pipeline, or if management has to cut the $1.60-$1.70 2027 EPS target again. Absent that, the balance of evidence still favors owning the repair rather than waiting for perfect optics.
≣ Full research note tap to expand
Executive Summary
BUY, Low conviction. Rated BUY, Low conviction. The setup is unusual: trailing fundamentals are ugly, with FY2025 EPS of -$0.51, -36.1% operating margin, and a headline 417.01x P/E, but the market is looking at a bank that has delivered three straight profitable quarters and now points to $1.60 to $1.70 of adjusted EPS in 2027. The stock is only 7.9% below its 52-week high, so this is not a washed-out panic entry, but the valuation against book and the capital cushion still leave upside if credit stabilizes and the C&I mix keeps replacing shrinking CRE and weaker mortgage revenue.
Investment Thesis
The market is still pricing FLG like a damaged regional bank, and on trailing numbers that is fair. FY2025 revenue fell 8.1% to $4.7B, operating margin was -36.1%, net margin was -29.0%, and the headline 417.01x P/E is useless for valuation because the earnings base has only just crossed back into positive territory. What creates the opportunity is that the operating direction has clearly changed before the accounting history has had time to catch up. The latest quarter showed third straight profitability, PPNR up 51% QoQ, expense control with opex down 3% QoQ to $427M, and a better funding profile with $700M core deposit growth ex-brokered.
The stock works if two things happen. First, commercial banking has to keep replacing runoff elsewhere. That part is tangible already: $2.8B of C&I originations, $2.0B net C&I growth, and a Q3 pipeline above $2B. Second, credit has to stop overwhelming income recovery. That is less proven. FLG reduced substandard loans by $375M QoQ and criticized/classified loans by 9% YoY, but nonaccruals are still $2.8B and charge-offs hit $99M in Q2. The company is improving, but it is not clean.
That tension is exactly why the stock is interesting but not a high-conviction call. At 0.73x book and 1.36x sales, the market is still skeptical that normalized earnings are durable. Yet management now has enough capital, with 13.16% CET1, to authorize a $250M buyback while continuing to pay down wholesale funding and reposition the loan book. That capital cushion matters because it gives FLG time to finish the repair without needing heroic macro help.
The rating stays BUY because the upside path does not require perfection, only continued evidence that 2026 is the transition year and 2027 is the earnings year. What keeps conviction low is simple: management cut guidance again, the latest quarter missed consensus by 21.8%, and the shares already sit just 7.9% below the 52-week high. This is a turnaround that now needs proof, not just promises.
Key Metrics
| Metric | Value | Context | ||
|---|---|---|---|---|
| Price target | $17.92 | 26.1% upside vs current $14.22, Low confidence, basis earnings_growth_blend | ||
| Current price / 52-week position | $14.22 | -7.9% vs $15.44 high, +6.9% above $13.31 200-day average, -66.4% vs 5-year high $42.33 | ||
| FY2025 revenue | $4.7B | -8.1% YoY, showing the turnaround has not yet reached the full-year P&L | ||
| FY2025 EPS | -$0.51 | -79.2% YoY, still poor on a trailing basis despite recent quarterly profitability | ||
| FY2025 operating margin | -36.1% | Worse than prior year's -21.6%, highlights how depressed the trailing cost/revenue structure remains | ||
| Valuation | P/E 417.01 | P/S 1.36 | P/B 0.73 | P/E is distorted and far above peer average 13.9, while P/S is below peer 3.1 and P/B implies skepticism on franchise quality |
| Balance sheet and leverage | Debt/Equity 1.34 | Total debt $10.9B | Leverage is meaningful but manageable in the context of a bank still rebuilding earnings and de-risking CRE | |
| Capital and buyback | CET1 13.16% | Buyback authorization $250M | Strong capital cushion is the key offset to ongoing credit stress | |
| Q2 2026 profitability | EBITDA $0.08B on $1.05B revenue | Margin 7.5%, up from 6.4% in Q1 and -3.6% in prior-year Q2 | ||
| Guidance | FY2026 adj. EPS $0.40-$0.50 | FY2027 adj. EPS $1.60-$1.70 | Outlook was cut, but still implies a sharp earnings ramp in 2027 | |
| Credit metrics | Nonaccrual loans $2.8B | Q2 net charge-offs $99M | Largest overhang, especially since management expects year-end nonaccruals around $2.3B | |
| Risk and short interest | Risk score 66/100 | Short interest 13.04% | Risk is high, but elevated short positioning can amplify upside if credit data improves |
Financial Strength
FLG's balance sheet is good enough to support the turnaround, but not good enough to remove doubt. The critical fact is 13.16% CET1, which gives management room to absorb credit cleanup, reduce expensive funding, and still authorize a $250M buyback. That offsets some concern around $10.9B of total debt and 1.34x debt/equity. Cash generation is still inconsistent, with reported FCF -$0.2B in the financial snapshot even as deep-dive data shows $0.2B FCF, so investors should focus less on reported free cash flow and more on capital, funding costs, and pre-provision earnings momentum. Margin trajectory is improving at the quarterly level, but the franchise still needs cleaner revenue mix and lower credit drag before it deserves a quality re-rating.
Competitive Position
FLG's moat is limited and comes from deposit relationships, commercial banking ties, and the ability to recycle excess capital into loan growth while weaker competitors stay defensive. That moat is not especially durable today because profitability is still rebuilding and the franchise has to earn back trust after credit issues. It becomes more durable only if management turns recent $700M core deposit growth and $2.0B C&I growth into a cleaner, lower-cost, relationship-heavy bank with less exposure to episodic mortgage and troubled CRE earnings.
Management & Guidance
Current guidance is a reset, not a collapse. CFO Lee Smith said, "EPS for '26 is now forecast to be in the $0.40 to $0.50 range and EPS for '27 is forecast to be in $1.60 to $1.70 range," while also framing June NIM as a floor. That guidance is believable only in part. The positive pieces are visible already, including $2.0B net C&I growth, lower deposit costs, and improving operating leverage. The weak point is credit, because nonaccruals at $2.8B sit above the expected $2.3B year-end level and the latest quarter still missed consensus. Management has improved operations, but the mixed beat/miss record means guidance deserves some discount until Q3 confirms the trend.
Segment Analysis
- Net revenue base ($4.7B FY2025 revenue): Revenue fell 8.1% YoY, reflecting pressure from balance-sheet shrink, funding mix, and weaker mortgage-related income.
- Commercial and industrial banking ($2.8B Q2 originations): This is the current growth engine, with $2.0B net C&I growth and a Q3 pipeline above $2B.
- Commercial and private bank deposits ($900M Q2 growth): Deposit mix is improving, which matters more than raw volume because lower-cost, relationship-based funding supports NIM recovery.
- Commercial real estate runoff ($1.1B Q2 par payoffs): CRE is intentionally shrinking; that lowers risk over time but is currently reducing earning assets and pressuring near-term NII.
- Mortgage-related revenue (Not separately disclosed in provided data): Management called out softer mortgage gain-on-sale as a reason for the lowered 2026-2027 outlook, indicating this is still a swing factor in mix quality.
Capital Allocation
Capital allocation has turned more credible now that CET1 stands at 13.16% and management authorized a $250M share buyback. That said, actual shareholder return has been minimal so far, with deep-dive data showing $0.0B buybacks and $0.0B dividends, which is appropriate while credit is still being cleaned up. The better use of capital today is balance-sheet repair, selective C&I growth, and paying down expensive funding, as shown by the $250M reduction in FHLB advances.
Management Execution & Track Record
Execution has improved, but credibility is still rebuilding. On the positive side, management said in 2024 Q3 that margin had bottomed, and current commentary from CFO Lee Smith, "I am looking at that as a floor, and that was the reason for pointing out the June NIM margin," suggests that directional view has largely held, with Q2 EBITDA margin improving to 7.5% from 6.4% in Q1 and -3.6% a year earlier. Management also kept the long-term 2027 frame alive in late 2024, and today still guides to $1.60-$1.70 adjusted EPS for 2027, even after cutting 2026 and 2027 outlook on the latest call. On the negative side, the 2024 warning that nonaccruals would stay elevated through 2026 proved accurate, and current $2.8B nonaccruals versus a $2.3B year-end target show the cleanup is taking longer than investors want. The earnings beat/miss record is mixed, with four beats and four misses across the last eight quarters, including the latest -21.8% miss, which argues for only low conviction despite clear operational progress.
Positioning & Flows
Ownership is concentrated, with the top three institutions holding 78.6%, which can stabilize the shareholder base but can also amplify moves when views change. Short interest is elevated at 13.04%, or 34.8M shares, with 7.4 days-to-cover, so the name can squeeze on cleaner credit data or a guidance hold. Options positioning is mildly supportive, with a positive gamma regime and zero-gamma at $13.24, below spot, which suggests near-term flows are not fighting the tape unless the stock breaks meaningfully lower.
Bull Case
- FLG posted its third straight quarter of profitability, with adjusted EPS improving to $0.05 from a $0.14 loss a year ago, showing the restructuring is finally producing visible earnings traction.
- Commercial banking is gaining momentum: $2.8B C&I originations produced $2.0B net C&I growth, and management said the Q3 pipeline is above $2B, which matters because C&I is replacing lower-quality or lower-return asset exposure.
- Funding and expense trends improved together in Q2, with $700M core deposit growth ex-brokered, $900M growth in commercial/private bank deposits, and a 5 bps QoQ reduction in interest-bearing deposit costs.
- Credit cleanup is painful but not directionless: substandard loans fell $375M QoQ, criticized and classified loans declined 9% YoY, and $1.1B of CRE runoff occurred at par, reducing balance sheet risk.
Bear Case
- Management cut both 2026 and 2027 outlooks, with FY2026 EPS now only $0.40-$0.50, because faster CRE payoffs, weaker DDA mix, and softer mortgage gain-on-sale are hitting NII and margin assumptions.
- Asset quality is still the core problem: Q2 net charge-offs rose to $99M, nonaccrual loans reached $2.8B, and that level is already above management's current FY2026 year-end expectation of $2.3B.
- Trailing profitability remains very weak, with FY2025 revenue down 8.1%, operating margin -36.1%, net margin -29.0%, and FCF -$0.2B in the financial snapshot, which explains the stock's low quality score of 31/100.
- The stock is no longer deeply discounted on near-term sentiment, trading 6.9% above its 200-day average and only 7.9% below its 52-week high, so any miss against the October setup could hit harder than if shares were still near the lows.
Valuation & Price Target
Engine price target $17.92 (+26.1% vs current), Low confidence.
- P/E Multiple: $0.34 (2% weight)
- P/S Multiple: $25.2 (20% weight)
- Quality-adjusted: $12.06 (20% weight)
This rating aligns with the quant baseline BUY, but for a more selective reason than the screen likely implies. The engine target is $17.92, with Low confidence, and that caution is warranted because trailing numbers are objectively poor: FY2025 EPS -$0.51, -36.1% operating margin, FCF -$0.2B, and a quality score of 31/100. The case for owning FLG rests almost entirely on direction of travel, not historical optics: three straight profitable quarters, 13.16% CET1, a $250M buyback authorization, and management's $1.60-$1.70 adjusted EPS target for 2027. Sell-side consensus is bullish, but that is low-signal context here; the real debate is whether credit improves fast enough for that earnings bridge to be believed.
Risk Assessment
Risk score 66/100 (High). The biggest risk is that credit normalization takes longer than management expects, because nonaccrual loans are $2.8B today versus a $2.3B year-end target, which would jeopardize the path from $0.40-$0.50 EPS in 2026 to $1.60-$1.70 in 2027.
The Bottom Line
FLG rates BUY, Low conviction. The stock is still a turnaround with real credit risk, but the combination of 0.73x book, 13.16% CET1, improving quarterly profitability, and a credible path to much higher 2027 earnings leaves room for upside from $14.22. This is not a clean story and it is not early in the price move, so sizing matters. The thesis breaks if nonaccruals fail to move down from $2.8B, if C&I growth stalls below the current $2B+ pipeline, or if management has to cut the $1.60-$1.70 2027 EPS target again. Absent that, the balance of evidence still favors owning the repair rather than waiting for perfect optics.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr